收藏切换
Synergistic aspirin derivatives treat hypoxic injury of coronary heart diseases
收藏切换
PDF
Wen ZHOU1, 2, Ping JIANG1, Wan-xiang YANG1, Shao-hua GOU1, 2, *
Acta Pharmaceutica Sinica | 2024, 59(10) : 2800 - 2808
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(10): 2800-2808
Synergistic aspirin derivatives treat hypoxic injury of coronary heart diseases
Full
Wen ZHOU1, 2, Ping JIANG1, Wan-xiang YANG1, Shao-hua GOU1, 2, *
Affiliations
  • 1. School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
  • 2. Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China
Published: 2024-10-12 doi: 10.16438/j.0513-4870.2024-0464
Outline
收藏切换

This study focuses on the microenvironment acidification caused by metabolic abnormalities and ion balance disturbances during cardiac ischemia, which can significantly trigger drug resistance and thus limit the therapeutic effect of coronary heart disease. To address this issue, we delve into the potential role of carbonic anhydrase inhibitors in enhancing drug efficacy through pH regulation. First, we evaluated the potential of the carbonic anhydrase inhibitor acetazolamide, in combination with aspirin, in alleviating myocardial hypoxic injury in a cellular model. Through high-throughput screening techniques, we systematically analyzed the synergistic effect of this drug combination and determined the optimal ratio. Next, we modified the structure of aspirin using acetazolamide as the structural basis, aiming to create novel derivatives with stronger myocardial protective activity. Using in vitro and in vivo models of myocardial hypoxic injury, we evaluated the biological activity and therapeutic efficacy of these derived compounds in detail. Animal experiments were approved by the Animal Ethics Committee of Southeast University (Ethics No. 20240109001). The results showed that the structurally modified aspirin derivatives exhibited significant synergistic effects in alleviating myocardial hypoxic injury. This study reveals the mechanism of action of carbonic anhydrase inhibitors in the treatment of coronary heart disease and provides experimental and theoretical evidence for the development of novel coronary heart disease treatment drugs, which has important guiding significance for drug design and coronary heart disease treatment strategies.

coronary heart disease  /  carbonic anhydrase inhibitor  /  aspirin derivative  /  hypoxia  /  synergy
Wen ZHOU, Ping JIANG, Wan-xiang YANG, Shao-hua GOU. Synergistic aspirin derivatives treat hypoxic injury of coronary heart diseases[J]. Acta Pharmaceutica Sinica, 2024 , 59 (10) : 2800 -2808 . DOI: 10.16438/j.0513-4870.2024-0464
Year 2024 volume 59 Issue 10
PDF
169
67
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0464
  • Receive Date:2024-05-15
  • Online Date:2025-11-24
  • Published:2024-10-12
Article Data
Affiliations
History
  • Received:2024-05-15
  • Revised:2024-07-18
Funding
Affiliations
    1. School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
    2. Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0464
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT